GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Stock Based Compensation

Embecta (FRA:JX7) Stock Based Compensation : €22 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Stock Based Compensation?

Embecta's Stock Based Compensation for the three months ended in Mar. 2024 was €6 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was €22 Mil.


Embecta Stock Based Compensation Historical Data

The historical data trend for Embecta's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Stock Based Compensation Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
Stock Based Compensation
10.90 10.78 10.88 18.89 20.15

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.23 5.08 4.59 6.69 5.98

Embecta Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €22 Mil.


Embecta Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Embecta's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta (FRA:JX7) Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines